Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Bayer Schering Launches MS Drug Betaferon

publication date: Sep 27, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Bayer Schering announced the China launch of Betaferon® (interferon beta-1b), a treatment for relapsing-remitting forms of multiple sclerosis (MS). The drug received SFDA approval for distribution in China last December. Bayer has introduced several products recently as it strives to make good on its promise to increase its revenues at a better than 20% rate. More details....

Stock Symbol: (XETRA: BAY)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors